Agenus Inc

NASDAQ:AGEN 11:38:49 AM EDT

4.59

+0.04 (+0.88%)

Market Cap (Intraday)	146.26M
Current PE	N/A
Forward PE	5.74
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$80.39 Million
Adjusted EPS	$2.20

See more estimates

10-Day MA	$4.54
50-Day MA	$5.11
200-Day MA	$3.71

See more pivots

Agenus Inc Stock, NASDAQ:AGEN

3 Forbes Road, Lexington, Massachusetts 02421-7305

United States of America

Phone: +1.781.674.4400

Number of Employees: 316

http://www.agenusbio.com

Description

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.